Physician profile
Weining David Xu
NPI 1326369711
$1,547.37
in general payments reported to CMS, 2019-2025
20 companies · $305 in 2025
The $305 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2021: $94.21 · 2022: $239 · 2023: $354 · 2024: $283 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $942.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $510.56 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $133.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $123.18 | 2021-2024 | |
| Pfizer INC. | $121.62 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $98.42 | 2024-2025 | Eliquis, Camzyos |
| Abiomed | $84.44 | 2023 | Impella |
| Inari Medical, INC. | $74.32 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Lexicon Pharmaceuticals, INC. | $69.06 | 2023-2024 | Inpefa |
| Astrazeneca Pharmaceuticals Lp | $62.38 | 2023-2024 | Farxiga, Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.07 | 2019-2024 | Lifevest |
| United Therapeutics Corporation | $29.90 | 2025 | Orenitram, Remodulin |
| Cvrx, INC. | $29.80 | 2024 | Barostim Neo System |
| Bayer Healthcare Pharmaceuticals INC. | $25.53 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.07 | 2025 | Jardiance |
| Novo Nordisk INC | $21.58 | 2023 | Rybelsus, Ozempic |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $21.43 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amicus Therapeutics, INC. | $20.20 | 2021 | |
| Scpharmaceuticals INC. | $17.80 | 2024 | |
| Sandoz INC. | $15.95 | 2021 | |
| Amgen INC. | $13.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weining Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.